Patients and Physicians for Rx Access and the International Academy of Compounding Pharmacists (IACP), today urge the Defense Health Agency to cover compounded medications without restriction under the TRICARE Health Plan, which provides healthcare benefits to more than 9.5 million uniformed service members, and their families.
In late 2014, the Department of Defense Pharmacy and Therapeutics (P&T) Committee recommended significant restrictions on ingredients commonly used in compounded formulations and a strict manual prior authorization process for prescribers and patients. In a win for patients and patient advocates, TRICARE’s Beneficiary Advisory Panel (BAP) rejected the P&T Committee’s unnecessarily restrictive and burdensome recommendations. Now faced with divergent committee recommendations, the final determination on the fate of compounded medication coverage for military heroes and families rests in the hands of the Director, TRICARE Management Activity.
“We understand the Defense Health Agency’s need to balance budget realities with patient access to care,” said Jay McEniry, executive director of Patients and Physicians for Rx Access. “In the span of a year, 140,000 military heroes and families filled 360,000 prescriptions for compounded medications. This includes children and veterans whose healthcare needs cannot be met by manufactured medicines. Clearly there is a need, and as a coalition we are committed to helping the Defense Health Agency find a way to manage costs without sacrificing care.”
IACP’s Executive Vice President/CEO David G. Miller, RPh, says, “IACP believes that all patients, regardless of their insurance plan, should have access to compounded medications whenever their physician determines that a compound is the best treatment for them.”
Please click here to read the press release.